TY - BOOK ID - 699614 TI - Guide to Targeted Therapies: EGFR mutations in NSCLC PY - 2014 SN - 3319030590 3319030582 PB - Cham : Springer International Publishing : Imprint: Adis, DB - UniCat KW - Epidermal growth factor. KW - Anthelone KW - EGF (Growth factor) KW - EGF-URO (Growth factor) KW - EGF-Urogastrone KW - Epidermal growth factor-Urogastrone KW - Uroanthelone KW - Uroenterone KW - Growth factors KW - Medicine. KW - Oncology  . KW - Pneumology. KW - Medicine/Public Health, general. KW - Oncology. KW - Pharmacotherapy. KW - Pneumology/Respiratory System. KW - Tumors KW - Clinical sciences KW - Medical profession KW - Human biology KW - Life sciences KW - Medical sciences KW - Pathology KW - Physicians KW - Health Workforce KW - Respiratory organs—Diseases. KW - Drug therapy KW - Pharmacotherapy KW - Therapeutics KW - Drugs KW - Pharmacology UR - https://www.unicat.be/uniCat?func=search&query=sysid:699614 AB - Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide. ER -